NCT02693730View on ClinicalTrials.gov

Phenotyping IBS: Perceptions and Modulations of Visceral Sensations

CompletedOBSERVATIONAL
Enrollment

198

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Irritable Bowel SyndromeUlcerative ColitisInflammatory Bowel Disease
Trial Locations (1)

90095

Oppenheimer Center for Neurobiology of Stress and Resilience, Los Angeles

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of California, Los Angeles

OTHER

NCT02693730 - Phenotyping IBS: Perceptions and Modulations of Visceral Sensations | Biotech Hunter | Biotech Hunter